Two critics of the Food and Drug Administration met with President-elect Donald Trump Thursday to discuss running the agency.
Silicon Valley insiders Jim O’Neill and Balaji Srinivasan have both called for major agency overhauls.
O’Neill’s candidacy for FDA commissioner was divulged last month. O’Neill is a managing director at Mithril Capital Management and a protégé of billionaire Peter Thiel, a key Trump transition adviser who initially proposed O’Neill for the job.
